NCT07439913

Brief Summary

The aim of the present project is to evaluate long-term oncological and functional treatment outcomes, as well as patient satisfaction, ten years after radical prostatectomy in patients initially enrolled in CPRRP study. This research builds on a previous five-year follow-up evaluation (approved by the ethics committee) and focuses on the durability of therapeutic effects, quality of life, and long-term complications. Data will be collected via telephone interviews assessing key parameters (PSA levels, information on subsequent radiotherapy and androgen-deprivation therapy, the ICIQ-SF and IIEF-5 questionnaires, and patient-reported quality-of-life and satisfaction measures), followed by statistical analysis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
9mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Feb 2026Feb 2027

Study Start

First participant enrolled

February 1, 2026

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2027

Last Updated

April 27, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

February 23, 2026

Last Update Submit

April 22, 2026

Conditions

Prostate Cancer (Adenocarcinoma)

Outcome Measures

Primary Outcomes (1)

  • Biochemical recurrence

    Prostate cancer biochemical recurrence rate

    From treatment to 10 years.

Secondary Outcomes (2)

  • Incontinence rate

    From surgery until 10 years.

  • Erectile dysfunction rate

    From surgery until 10 years.

Interventions

Radical prostatectomyPROCEDURE

Robot assisted radical prostatectomy

Eligibility Criteria

Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All participats of the initial CPRRS study

You may qualify if:

  • Robot assisted radical prostatectomy performed in CPRRP study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

F.D. Roosvelt university hospital

Banská Bystrica, Slovakia

Location

MeSH Terms

Conditions

Prostatic NeoplasmsAdenocarcinoma

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic Type

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

February 23, 2026

First Posted

February 27, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

February 18, 2027

Study Completion (Estimated)

February 18, 2027

Last Updated

April 27, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations

SL(1)